Thought Leadership, Whitepapers, Webinars and More on Precision Prescribing
How GenXys Health Care Systems’ Technology Can Make An Important Impact On Our Overall Wellness
The Medium are interviewing leaders of tech companies who are creating or have created a tech product that is helping to make a positive change in people’s lives or the environment.
Read the Article
The Case for Education and Clinical Decision Support With Pharmacogenetics
Prescribing is a complex process with multiple factors to consider on top of the 3 primary questions about effectiveness, harm, and cost. Pharmacogenetics has put this complexity under the spotlight and prompted educational programs and the development of new clinical decision support systems.
Read the Article
Precision Prescribing Can Advance Mental Health Treatment
Pharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.
Read the Article
How Congress Could Play a Role in Personalized Medicine
PGx — a tool to help determine proper dosing — may be poised to achieve broader use in healthcare and pharma.
Read the Article
Designing a PGx Program That Works
The Power and the Promise: Integrating Pharmacogenomics into Clinical Practice
Read the Article
Putting PGx into Practice
An interview with Bernard Esquivel, Chief Medical Officer, GenXys Health Care Systems.
Read the Article
Evidence driven platform integrated into an EHR
The essentials for a powerful clinical decision support software with embedded PGx.
Read the Article
Potential Impact of Pharmacogenetics on Prescriptions
Millions of prescriptions are potentially affected by pharmacogenetics every year.
Read the white paper
Precision Prescribing Software Global Review
With precision prescribing software, we can take advantage of new discoveries. We can stem the epidemic of adverse drug events.
Read the white paper
Unlocking Precision Medicine: Implementing a Novel Pharmacogenomics Prescribing Program
This time around, with the help of our special guests, Dr. Otito Frances Iwuchukwu, and Heather Gerich, we will explore the barriers and challenges in setting up a precision medicine and pharmacogenetics (PGx) program, and how a health system was able to implement one in one month.
Precision Medicine Throughout your Life: Senior Living and Beyond
This time around, with the help of our special guests, DeLon Canterbury, Howard McLeod, and Thu Nguyen, we will explore the important part that precision medicine and pharmacogenetics (PGx) play in supporting senior living and it’s applications for the rest of the patient population.
Driving PGx Adoption: Proven Implementations to reduce ADRs by 30%
Hear from our special guests, George Patrinos, Professor and Head of Laboratory at the University of Patras and Editor-in-Chief of The Pharmacogenomics Journal, Sara Rogers, President of the American Society for Pharmacovigilance and Clinical Assistant Professor at Texas A&M University, and Dr. Richard Turner, Director – Physician in Genomic Sciences at GSK, we will be discussing proof points which help in pharmacogenetics (PGx) adoption and the PREPARE study.
The finale of our three-part webinar series, A New Era of Precision Medicine, hosted by Dave Wolfe, will be joined by industry experts Jay Weaver, pharmacy benefits executive, and pharmacist, Sara Rogers, president of the American Society for Pharmacovigilance and clinical assistant professor, and Vicky Pratt, VP of Molecular Diagnostics Quality Assessments at Optum Genomics, for a round table discussion about the role of payors in the genomic era and how precision prescribing with pharmacogenetics (PGx) is macro-trending.
In the second episode of a three-part series, leading industry experts Amy Berk, Director of Population Health at Microsoft, Dr. David Kisor, Director of the Master of Science in Pharmacogenomics Program at Manchester University, and Dr. Robin Everts, Senior Manager of Global Pharmacogenetics & Clinical Genetics at Agena Bioscience®, will discuss the importance of the infrastructure that is needed for a successful pharmacogenetics (PGx) initiative built for scalability, geographic reach, and regulatory oversight.
Get access to our on-demand webinar to answer these questions and learn more.
A New Era of Precision Medicine, Part I feat. Sir Munir Pirmohamed
In the first episode of a three-part series, join Precision Medicine advocate and US PGx program implementation specialist, Dr. Bernard Esquivel and Professor Sir Munir Pirmohamed, NHS Chair of Pharmacogenetics, University of Liverpool, as they engage in a lively conversation about how different countries are moving away from a one size fits all approach towards truly personalized medicine.
Get access to our on-demand webinar to answer these questions and learn more.
The RIGHT Act: Is this the catalyst for universal precision medicine through precision prescribing?
Watch Representatives Swalwell and Emmer’s important conversation that will change the way you think about precision medicine and the healthcare system, integrating Clinical Decision Support Software (CDSS) with the use of pharmacogenetic testing to avoid Adverse Drug Events (ADE).
Get access to our on-demand webinar to answer these questions and learn more.
Beyond PGx Reporting: How an innovative PGx lab is providing a PGx 2.0 service
Precision Genetics is at the forefront of the personalized medicine revolution. Watch this exclusive webinar to hear about three emerging trends in the marketplace and how they’ll impact your work.
Get access to our on-demand webinar to answer these questions and learn more.
Precision prescribing and pharmacogenomics have a key role to play in optimizing and improving patient outcomes in community care, but ensuring scalability and seamless integration is critical to its implementation. Dr. Akwasi Asabere, population genomics expert & Strategic Partnerships Director at Helix shares his insights on how we can utilize population genomics to overcome current barriers & provide actionable pharmacogenomic results as standard of care. The webinar is hosted by Dr. Bernard Esquivel, Chief Medical Officer at GenXys.
Get access to our on-demand webinar to answer these questions and learn more.
GenXys’ Canadian Precision Health Symposium.
Thinking of implementing Pharmacogenetics (PGx)? Wanting to learn more about PGx as an extended health benefit?
Get access to our on-demand webinar to answer these questions and learn more.
Pharmacogenetics: Identifying who to test and when to intervene with PGx information.
Who should get a PGx test? When will clinical intervention be needed? Thinking about implementing pharmacogenetics but don’t know how to start?
Get access to our on-demand webinar to learn more.
CYP2D6 & CYP2C9: Understanding their role, interpretation, and clinical inclusion.
The best guidelines like CPIC have to be updated regularly to keep up with the latest research—how are you keeping up with the guidelines?
Get access to our on-demand webinar to learn more.
Ever wondered what pharmacogenetics is? How it helps companies reduce healthcare costs and improve population health?
Join our webinars to learn more.
Precision Prescribing Software Global Review
Learn about the state-of-the-art of precision prescribing software with our infographic.
Saying Goodbye to One-size-fits-all Treatments
Precision prescribing is essential rather than optional infographic.
Helen Smith, Martin Dawes, Hagit Katzov-Eckert, Sarah Burrell, Sam Xin Hui, Michael D Winther, Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore, Family Practice, 2022;, cmac124, Link
Dawes, M. et al. Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study. cmajo 4, E528–E534 (2016). Link
Sidney Ang, J. et al. Evaluation of buccal swabs for pharmacogenetics. BMC Res. Notes 11, 382 (2018). Link